1. Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma
   Yu-Hsuan Kuo et al, 2021, Frontiers in Oncology CrossRef
2. Proteomic and Phosphoproteomic Profiling Reveals the Oncogenic Role of Protein Kinase D Family Kinases in Cholangiocarcinoma
   Yun Lu et al, 2022, Cells CrossRef
3. High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma
   Muntinee Lertpanprom et al, 2022, Frontiers in Public Health CrossRef
4. Role of Glucose Metabolism Reprogramming in the Pathogenesis of Cholangiocarcinoma
   Kishor Pant et al, 2020, Frontiers in Medicine CrossRef
5. The Implications of PDK1–4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance
   Emine Atas et al, 2020, Frontiers in Oncology CrossRef
6. Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma
   Hanjiao Qin et al, 2023, Frontiers in Pharmacology CrossRef